Unlocking Cancer Treatment Potential: Targeting STAT Proteins Holds Key
The STAT family of proteins plays a crucial role in regulating cell processes and has been linked to cancer development and treatment resistance. Specifically, STAT3 and STAT5 are important in cancer biology, acting as both oncogenes and tumor suppressors. Mutations in STAT signaling and abnormal activation of STAT pathways could help predict how well a patient responds to immunotherapy and targeted treatments. This review explores the potential of targeting STAT proteins in cancer treatment, highlighting their dual role in promoting and inhibiting tumor growth.